Overview
- 14 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-06-27.
At a glance
Inspections
14
Form 483s
5
EIRs
5
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 22 Jun 2023 – 27 Jun 2023 | Foods & Cosmetics | Clean | |
| 19 Sep 2022 – 22 Sep 2022 | Human Drugs | 483 | View 483 → |
| 1 Apr 2019 – 4 Apr 2019 | Human Drugs | 483 | View 483 → |
| 19 Sep 2018 – 20 Sep 2018 | Foods & Cosmetics | Clean | |
| 1 May 2017 – 4 May 2017 | Foods & Cosmetics | Clean | |
| 31 Mar 2015 – 9 Apr 2015 | Medical Devices & Rad Health | 483 | On file |
| 27 Jan 2014 – 7 Feb 2014 | Human Drugs | 483 | View 483 → |
| 25 May 2012 | Not recorded | 483 | View 483 → |
| 20 Jul 2010 | Not recorded | Clean | |
| 12 Mar 2010 | Not recorded | Clean | |
| 16 May 2008 | Not recorded | Clean | |
| 27 May 2005 | Not recorded | Clean | |
Observations on record
Form 483 observations cited at this site, most recent first.
22 Sep 2022
21 CFR 211.56(a)
Sanitation--buildings not clean, free of infestation
Cited by Michelle A Krayer
4 Apr 2019
21 CFR 211.58
Buildings not maintained in good state of repair
Cited by Margaret M Annes, Anitha P Govada
7 Feb 2014
21 CFR 211.110(a)
Written in-process control procedures
Cited by Lucas B Leake, Diana L Ayala
Investigators
FDA investigators tied to this site in the record.
Rian L Pope2 insp.
Stephen D Brown2 insp.
Jonaida Estevez Martinez1 insp.
Michelle A Krayer1 insp.
Margaret M Annes1 insp.
Anitha P Govada1 insp.
CntrctMntr YoungJD1 insp.
Lucas B Leake1 insp.
Diana L Ayala1 insp.
Karen C Daugherty1 insp.
Scott T Ballard1 insp.
Jodi M Gatica1 insp.
Tricia S Martinez1 insp.
Emilio O Escobar1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.58 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.81(b)(1)(ii) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Mission Pharmacal Company's 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat